NexImmune ^Company

NexImmune is a biopharmaceutical company that is focused on developing novel immuno-therapeutics based on their proprietary Artificial IMmune (AIMTM) technology. Their AIM technology allows for the development of immunotherapies for various cancers and diseases by orchestrating specific immune system responses in a controlled and reproducible manner. The company's goal is to deliver immunotherapies that have curative potential and go beyond incremental improvements. They achieve this through their unique approach of modulating the role of T cells within the immune system using their proprietary nanotechnology platform, AIM. This platform directs specific T cell-mediated immune responses to treat a range of diseases.